NCI Explores AI’s Potential for Cancer Screenings
Dr. Katrina Goddard, Director, Division of Cancer Control and Population Sciences, NCI
The National Cancer Institute (NCI) is exploring how it can leverage artificial intelligence to enhance cancer screening techniques, ultimately improving patient outcomes across the nation.
Dr. Katrina Goddard, director of the Division of Cancer Control and Population Sciences at NCI, explains how her division is leveraging AI, and other innovative solutions like the low-dose CT scan, to better detect lung cancer and enable better access to data.
Goddard also shares details from a recent study that highlighted the major role screenings and prevention have played in decreasing the cancer mortality rates over the past 40 years.
-
Dr. Katrina Goddard Director, Division of Cancer Control and Population Sciences, NCI
-
EHR Rollout On Track, VA Deputy Secretary Tells Congress
VA officials told Congress the renewed EHR rollout is on schedule and exceeding expectations as deployments expand across the country.
3m read -
How Federal Health Agencies Are Scaling AI Pilots
NIAID’s platform and NIH’s Bio Genesis Mission reflect a broader push to move AI into mission workflows and accelerate biomedical discovery.
-
Federal Health Agencies Are Using AI to Improve Care
Federal health leaders are deploying AI for nursing home safety, virtual clinical training and more connected pediatric care.
4m read -
Faster AI Adoption Starts With Smarter Federal Acquisition
NIH, HHS and industry leaders outline ways to speed procurement, preserve human oversight and close the gap between AI pilots and production.
2m read
